New 13D18
New 13G54
Stated intents3
The week of 2026-02-23, 18 holders filed a new Schedule 13D and 54 a new Schedule 13G reporting 5% or more of a company, and 3 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-02-26 | Patria Investments Ltd. | Olimpio Matarazzo Neto | 56% | SCHEDULE 13D |
| 2026-02-26 | ContextLogic Holdings Inc. | Abrams Capital Management, L.P. | 40% | SCHEDULE 13D |
| 2026-02-24 | Aberdeen Government Markets Income Fund | Sit Investment Associates Inc | 27.9% | SCHEDULE 13D |
| 2026-02-24 | Willow Lane Acquisition Corp. II | Willow Lane Sponsor II, LLC | 27.9% | SCHEDULE 13D |
| 2026-02-24 | Aberdeen Intermediate Income Fund | Sit Investment Associates Inc | 25.2% | SCHEDULE 13D |
| 2026-02-27 | Paloma Acquisition Corp I | Paloma Capital Group LLC | 20.46% | SCHEDULE 13D |
| 2026-02-27 | Averin Capital Acquisition Corp. | Averin Capital Acquisition Sponsor LLC | 20.44% | SCHEDULE 13D |
| 2026-02-24 | Radcom Ltd | Lynrock Lake LP | 19.3% | SCHEDULE 13D |
| 2026-02-27 | Nakamoto Inc. | David Bailey | 17.33% | SCHEDULE 13D |
| 2026-02-23 | Arcellx, Inc. | Gilead Sciences, Inc. | 11.5% | SCHEDULE 13D |
| 2026-02-24 | Mfs Charter Income Trust | Sit Investment Associates Inc | 9.8% | SCHEDULE 13D |
| 2026-02-24 | Mfs Intermediate High Income Fund | Sit Investment Associates Inc | 9.2% | SCHEDULE 13D |
| 2026-02-24 | Noodles & Company | Galloway Capital Partners, LLC | 8.78% | SCHEDULE 13D |
| 2026-02-27 | Azul S.A. | United Airlines Holdings, Inc. | 8.7% | SCHEDULE 13D |
| 2026-02-25 | Compass Diversified Holdings | ADW Capital Partners, L.P. | 7.6% | SCHEDULE 13D |
| 2026-02-24 | Turtle Beach Corp | Hoak Public Equities, LP | 5.17% | SCHEDULE 13D |
| 2026-02-25 | Rayonier Advanced Materials Inc. | AIPCF VIII (Cayman), Ltd. | 5.07% | SCHEDULE 13D |
| 2026-02-25 | Power REIT | Bradley & Daytona Railway and Land Co. LLC | 5.01% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-02-26 | Manulife GA Trust | Manufacturers Life Insurance Company | 100% | SCHEDULE 13G |
| 2026-02-25 | CCH Holdings Ltd | Goh Kok Foong | 44.28% | SCHEDULE 13G |
| 2026-02-26 | Eastern International Ltd. | Albert Wong | 40.5% | SCHEDULE 13G |
| 2026-02-27 | Sound Point Direct Lending BDC | Assured Guaranty Ltd. | 21.7% | SCHEDULE 13G |
| 2026-02-23 | LendingTree, Inc. | Greuling Megan | 17.59% | SCHEDULE 13G |
| 2026-02-26 | Nakamoto Inc. | Bailey Calli Sullivan | 16% | SCHEDULE 13G |
| 2026-02-27 | Infleqtion, Inc. | Tyler Brous | 14.1% | SCHEDULE 13G |
| 2026-02-27 | Grindr Inc. | James Fu Bin Lu | 12% | SCHEDULE 13G |
| 2026-02-23 | Infleqtion, Inc. | W. Grant Dollens | 11.9% | SCHEDULE 13G |
| 2026-02-27 | Pasithea Therapeutics Corp. | Coastlands Capital LP | 9.99% | SCHEDULE 13G |
| 2026-02-27 | Bimergen Energy Corp | Encompass Capital Advisors LLC | 9.99% | SCHEDULE 13G |
| 2026-02-24 | Immunic, Inc. | Commodore Capital LP | 9.9% | SCHEDULE 13G |
| 2026-02-24 | X3 Holdings Co., Ltd. | Streeterville Capital LLC | 9.9% | SCHEDULE 13G |
| 2026-02-24 | Netclass Technology Inc. | Streeterville Capital LLC | 9.9% | SCHEDULE 13G |
| 2026-02-25 | Faeth Therapeutics, Inc. | Trails Edge Capital Partners, LP | 9.9% | SCHEDULE 13G |
| 2026-02-25 | 20/20 Biolabs, Inc. | Streeterville Capital LLC | 9.9% | SCHEDULE 13G |
| 2026-02-27 | Valion Bio, Inc. | 3i, LP | 9.9% | SCHEDULE 13G |
| 2026-02-27 | Eason Technology Ltd | Bucktown Capital LLC | 9.9% | SCHEDULE 13G |
| 2026-02-24 | Trupanion Inc | Felix Holdings Bv | 9.89% | SCHEDULE 13G |
| 2026-02-24 | Spruce Biosciences, Inc. | Integrated Core Strategies (US) LLC | 9.6% | SCHEDULE 13G |
| 2026-02-24 | Appian Corporation | RPD Fund Management LLC | 9.1% | SCHEDULE 13G |
| 2026-02-27 | Azul S.A. | Readystate Asset Management, LP | 9% | SCHEDULE 13G |
| 2026-02-24 | Immunic, Inc. | Trails Edge Capital Partners, LP | 8.7% | SCHEDULE 13G |
| 2026-02-24 | QHSLab, Inc. | Nicholas Peters | 8.65% | SCHEDULE 13G |
| 2026-02-27 | Azul S.A. | BlackBarn Capital Partners LP | 8.4% | SCHEDULE 13G |
| 2026-02-25 | Canaan Inc | Cipher Digital Inc. | 7.7% | SCHEDULE 13G |
| 2026-02-25 | United Homes Group, Inc. | Hilary L. Shane | 7% | SCHEDULE 13G |
| 2026-02-25 | Templeton Emerging Markets Fund | State of Wisconsin Investment Board | 6.73% | SCHEDULE 13G |
| 2026-02-26 | Capricor Therapeutics, Inc. | Suvretta Capital Management, LLC | 6.6% | SCHEDULE 13G |
| 2026-02-27 | Borealis Foods Inc. | Alta Partners LLC | 6.3% | SCHEDULE 13G |
| 2026-02-24 | Lovesac Co | Brian Gaines | 6.28% | SCHEDULE 13G |
| 2026-02-24 | Calavo Growers Inc | Fourth Sail Capital LP | 6.21% | SCHEDULE 13G |
| 2026-02-27 | Tectonic Therapeutic, Inc. | Chen Yu | 6.2% | SCHEDULE 13G |
| 2026-02-26 | Open Lending Corporation | Portolan Capital Management, LLC | 5.93% | SCHEDULE 13G |
| 2026-02-23 | Willow Lane Acquisition Corp. II | RP Investment Advisors LP | 5.9% | SCHEDULE 13G |
| 2026-02-27 | OFA Group | Greentree Financial Group, Inc. | 5.88% | SCHEDULE 13G |
| 2026-02-25 | Jasper Therapeutics, Inc. | Integrated Core Strategies (US) LLC | 5.8% | SCHEDULE 13G |
| 2026-02-23 | Abony Acquisition Corp. I | Linden Capital L.P. | 5.7% | SCHEDULE 13G |
| 2026-02-25 | Armada Acquisition Corp. III | Linden Capital L.P. | 5.5% | SCHEDULE 13G |
| 2026-02-26 | Orion S.A. | Divisar Capital Management LLC | 5.5% | SCHEDULE 13G |
| 2026-02-23 | Vine Hill Capital Investment Corp. II | RP Investment Advisors LP | 5.4% | SCHEDULE 13G |
| 2026-02-23 | Enviri LLC | Davidson Kempner Credit Investments LP | 5.31% | SCHEDULE 13G |
| 2026-02-25 | Paloma Acquisition Corp I | Tenor Capital Management Company, L.P. | 5.3% | SCHEDULE 13G |
| 2026-02-27 | Azul S.A. | VR Advisory Services Ltd | 5.3% | SCHEDULE 13G |
| 2026-02-27 | Everquote Inc | Millennium Management LLC | 5.3% | SCHEDULE 13G |
| 2026-02-23 | Beta Bionics, Inc. | Point72 Asset Management, L.P. | 5.2% | SCHEDULE 13G |
| 2026-02-23 | Gilat Satellite Networks Ltd | Harel Insurance Investments & Financial Services Ltd | 5.2% | SCHEDULE 13G |
| 2026-02-23 | Brainsway Ltd. | Harel Insurance Investments & Financial Services Ltd | 5.2% | SCHEDULE 13G |
| 2026-02-27 | C3is Inc. | Alta Partners LLC | 5.2% | SCHEDULE 13G |
| 2026-02-26 | Paloma Acquisition Corp I | Sculptor Capital LP | 5.16% | SCHEDULE 13G |
| 2026-02-27 | White Pearl Acquisition Corp. | Harraden Circle Investments, LLC | 5.15% | SCHEDULE 13G |
| 2026-02-24 | Eyepoint, Inc. | Paradigm BioCapital Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-02-24 | MainStreet Bancshares, Inc. | MainStreet Bank 401(k) Retirement Plan | 5.1% | SCHEDULE 13G |
| 2026-02-24 | Avalo Therapeutics Inc | Millennium Management LLC | 5% | SCHEDULE 13G |
Stated intent
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-02-23 | GeoPark Limited | Parex Resources Inc. intent stated | 11.8% | SCHEDULE 13D/A |
| 2026-02-26 | Sturm Ruger & Co Inc | Beretta Holding S.A. intent stated | 9.95% | SCHEDULE 13D/A |
| 2026-02-23 | Empery Digital Inc. | Brown, Tice intent stated | 9.8% | SCHEDULE 13D/A |
Download this data (CSV)75 rows, with sources
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.